TGFB1 and neoplasm: In addition to killer proteins, NK cell-derived Exos may also carry tumor suppressor miRNAs such as miR-186, and thus inhibiting tumor growth and TGFβ1-dependent immune escape, and all of which exhibited the therapeutic potential of NK cell-derived Exos (57).